Pioneering Supplement Brand Scores Three-Year Revenue Growth of 124%
CARLSBAD, Calif., Sept. 3, 2025 /PRNewswire/ -- Qualia Life Sciences, a supplement company known for breakthrough formulations , just achieved the 2025 Inc. 5000 nearly a decade after its founding due to remarkable recent growth. The Inc. 5000 is a prestigious annual list honoring the 5,000 private American companies with the highest percentage revenue growth over their most recent three year period. That metric heavily favors very young startups able to achieve explosive growth percentages in their first few years.
Qualia previously achieved the INC 5000 honor in 2020 and 2021, but to accomplish it a decade into existence required a series of extraordinary successes at a larger scale.
"Several elements lined up for us to achieve our recent trajectory" states Qualia CEO James Schmachtenberger. "Two products of ours released in the last three years, Qualia Senolytic and Qualia NAD+, have had explosive growth, becoming top selling products. We've also achieved clinical proof of Qualia NAD+ boosting NAD levels by 67%, further bolstering its sales. It's a truly exciting time to be part of our team."
Qualia also recently achieved the 2025 Nutrition Business Journal Award for Science & Innovation, and their products can now be found in major national retailers like GNC and Sprouts. Companies such as Microsoft, Intuit, Patagonia, Zappos and many other Fortune 1000 giants gained early national exposure by achieving inclusion in the annual INC. 5000 list.
"We subject every product we release to human studies before hitting the market." adds Schmachtenberger. "Our expertise has always been the way certain ingredients do or do not work together for a health need. We invest decisively in research and testing to leverage that expertise. It's exciting that our approach is being recognized both in revenue growth and industry awards."
About Qualia Life Sciences:
Founded in 2015, Qualia Life Sciences advances human well-being through complex systems science—studying how the body's interconnected systems self-regulate and heal. The company does not just claim high standards; it proves them with studies on every product it releases, including open-label and double-blind, placebo-controlled trials. Their research-driven portfolio includes support for brain health, senescent cells, NAD+levels, Magnesium levels, and much more. Learn more about their approach at qualialife.com.
SOURCE Qualia Life Sciences

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

Newsrooms &
Influencers

Digital Media
Outlets

Journalists
Opted In
Share this article